Back to Search

A Phase 1b-2, Multicenter, Trial to Evaluate the Efficacy, Safety, Pharmacokintetics, and Pharmacodynamics of REC-4881 in Patients with Familial Adenomatous Polyposis (FAP)

  • Protocol Number: 202408140
  • Principal Investigator: Wise, Paul
  • Cancer Types: Gastrointestinal

Learn more about this study at: clinicaltrials.gov

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

This is a multicenter, two-part trial in participants with Familial Adenomatous Polyposis (FAP).

Protocol Interventions

Drug: REC-4881